![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gyg Plc | LSE:GYG | London | Ordinary Share | GB00BZ4FM652 | ORD GBP0.002 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 30.00 | 25.00 | 45.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
RNS Number:8031R Gyrus Group PLC 07 November 2003 For release 7.00 am, 7th November 2003 Gyrus Group PLC Gyrus announces acquisition of Explorent GmbH for up to Euro 5.5 million 7th November, 2003, Reading, UK - Gyrus Group (GYG.L), a leading supplier of medical devices to reduce trauma and complications in surgery, today announces the acquisition of Explorent GmbH ("Explorent"), a sourcing and distribution business for surgical instruments used in Ear, Nose and Throat ("ENT") surgery, for up to Euro 5.5 million in cash. Explorent, based in Tuttlingen, Germany, sells its branded products throughout the world via distribution partners. The acquisition provides Gyrus with a platform from which to grow its German business and develop its own source of reusable surgical instruments similar to those currently purchased from third parties. For the year to 31st December 2002, Explorent had revenues of approximately Euro 5.5 million and profit before tax of approximately Euro 891,000. Net assets at 31st December 2002 amounted to Euro 1.2 million. Gyrus is paying Euro 5.0 million on completion and up to Euro 0.5 million by 31st October 2004. The acquisition of Explorent is a further step in the development of the Group's international strategy and follows the recent acquisition of Entermed B.V. in September 2003. Entermed B.V. currently distributes Gyrus's range of ENT products within a broader product portfolio, including Explorent's surgical instrument range, to surgeons in Benelux. Commenting on the acquisition, Brian Steer, Executive Chairman of Gyrus, said today: "The acquisition of Explorent represents both an expansion for Gyrus into the growing ENT market in Germany and an opportunity to gain cost efficiencies in our sourcing of surgical instruments for the important world-wide ENT market." Enquiries: Gyrus Group PLC Brian Steer, Executive Chairman 01189 219 750 Simon Shaw, Chief Financial Officer Today 07739 807 625 Thereafter 01189 219750 Financial Dynamics David Yates / Lucy Briggs 0207 269 7156 This information is provided by RNS The company news service from the London Stock Exchange END ACQGLBDBUUGGGXR
1 Year Gyg Chart |
1 Month Gyg Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions